Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Alliance University is a Private University established in Karnataka State by Act No. 34 of the year 2010. The University is recognized by the University Grants Commission (UGC), New Delhi. Alliance
-
Overview National Institute for Materials Science (NIMS) is launching an international open call for outstanding researchers who can drive world-class research in materials science, to further
-
continuous review of academic policies, regulations, and procedures in collaboration with academic and professional service departments. Ensure systems and processes support academic integrity, curriculum
-
Queen's Business School (QBS) at Queen’s University Belfast (QUB) is currently seeking to appoint one or more exceptional candidates to the post of Lecturer/Senior Lecturer in Finance/Financial
-
://group.springernature.com/ and follow @SpringerNature / @SpringerNatureGroup. About the Role Scientific Reports is a primary research journal from the publishers of Nature, covering all areas of the natural sciences
-
to champion the Bachelor of Business Administration program at Hult International Business School. Every interaction is an opportunity to embody our values and showcase our innovative approach to higher
-
Qualifications: Ph.D./M.A. in American Studies, Political Science, International Relations, or related fields. Prior engagement with US-India issues is a strong preference. APPLICATION PROCESS Documents Required
-
and Technology of the People’s Republic of China. The chief scientist is Academician Xu Nanping. The director of MCE is Prof. Jin Wanqin. The main discipline of Chemical Engineering and Technology, for
-
careers in private companies. The research field to be recruited: One position is available in each of the 9 fields specified below. R25-03 Battery Materials and Characterization R25-04 Magnetic
-
Company Description Biogen’s West Coast Hub, based in South San Francisco, is specifically focused on transforming the lives of patients with severe immune-mediated diseases by developing novel